Increasing involvement of CAPN1 variants in spastic ataxias and phenotype-genotype correlations.


Journal

Neurogenetics
ISSN: 1364-6753
Titre abrégé: Neurogenetics
Pays: United States
ID NLM: 9709714

Informations de publication

Date de publication:
03 2021
Historique:
received: 04 12 2020
accepted: 31 12 2020
pubmed: 25 1 2021
medline: 19 11 2021
entrez: 24 1 2021
Statut: ppublish

Résumé

Spastic ataxias are rare neurogenetic disorders involving spinocerebellar and pyramidal tracts. Many genes are involved. Among them, CAPN1, when mutated, is responsible for a complex inherited form of spastic paraplegia (SPG76). We report the largest published series of 21 novel patients with nine new CAPN1 disease-causing variants and their clinical characteristics from two European university hospitals (Paris and Stockholm). After a formal clinical examination, causative variants were identified by next-generation sequencing and confirmed by Sanger sequencing. CAPN1 variants are a rare cause (~ 1.4%) of young-adult-onset spastic ataxia; however, together with all published cases, they allowed us to better describe the clinical and genetic spectra of this form. Truncating variants are the most frequent, and missense variants lead to earlier age at onset in favor of an additional deleterious effect. Cerebellar ataxia with cerebellar atrophy, dysarthria and lower limb weakness are often associated with spasticity. We also suggest that cognitive impairment and depression should be assessed specifically in the follow-up of SPG76 cases.

Identifiants

pubmed: 33486633
doi: 10.1007/s10048-020-00633-2
pii: 10.1007/s10048-020-00633-2
pmc: PMC7997841
doi:

Substances chimiques

Calpain EC 3.4.22.-
CAPN1 protein, human EC 3.4.22.52

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

71-79

Références

Neurol Genet. 2018 Jan 18;4(1):e218
pubmed: 29379883
Nucleic Acids Res. 1987 Sep 11;15(17):7155-74
pubmed: 3658675
J Comput Biol. 2004;11(2-3):377-94
pubmed: 15285897
Neurogenetics. 2018 May;19(2):111-121
pubmed: 29691679
Int J Neurosci. 2020 May 13;:1-13
pubmed: 32352326
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894
pubmed: 30371827
Clin Genet. 2018 Nov;94(5):482-483
pubmed: 30198554
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Eur J Hum Genet. 2020 Aug;28(8):1034-1043
pubmed: 32214227
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669
Eur J Hum Genet. 2017 Nov;25(11):1217-1228
pubmed: 28832565
Cerebellum. 2019 Aug;18(4):781-790
pubmed: 31104286
Cell Rep. 2016 Jun 28;16(1):79-91
pubmed: 27320912
Eur J Med Genet. 2019 Dec;62(12):103605
pubmed: 30572172
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Pract Neurol. 2018 Oct;18(5):369-372
pubmed: 29678961
Case Rep Neurol Med. 2019 Jul 1;2019:7615605
pubmed: 31355030
Rev Neurol (Paris). 2019 Oct;175(9):572-574
pubmed: 31147273
J Neurol Sci. 2020 Apr 15;411:116691
pubmed: 31982778
Am J Hum Genet. 2016 May 5;98(5):1038-1046
pubmed: 27153400
JAMA Neurol. 2018 May 1;75(5):591-599
pubmed: 29482223
Curr Opin Neurol. 2018 Aug;31(4):462-471
pubmed: 29847346
Mov Disord. 2011 Apr;26(5):870-6
pubmed: 21437988
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W452-7
pubmed: 22689647
J Neurol Sci. 2017 Jul 15;378:210-212
pubmed: 28566166
Clin Rehabil. 2009 Sep;23(9):857-61
pubmed: 19561033
J Neurol. 2017 May;264(5):1008-1010
pubmed: 28321562
Trends Neurosci. 2016 Apr;39(4):235-245
pubmed: 26874794
J Neurol. 2019 Nov 19;:
pubmed: 31745725
J Comput Biol. 1997 Fall;4(3):311-23
pubmed: 9278062
Transl Neurodegener. 2019 Jun 26;8:19
pubmed: 31289639
Ann Clin Transl Neurol. 2020 Oct;7(10):1862-1869
pubmed: 32860341
Mov Disord. 2017 Mar;32(3):332-345
pubmed: 28195350
Front Neurol. 2019 Jun 05;10:580
pubmed: 31231303
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Orphanet J Rare Dis. 2019 Apr 25;14(1):83
pubmed: 31023339

Auteurs

Jean-Loup Méreaux (JL)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, DMU Neuroscience 6, Paris, France.
Rouen University Hospital, Rouen, France.
Paris Sciences et Lettres University, EPHE, Paris, France.

Cristina Firanescu (C)

Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.

Giulia Coarelli (G)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, DMU Neuroscience 6, Paris, France.
APHP, National Reference Center for Rare Diseases 'Neurogenetic', Department of Genetics, Pitié-Salpêtrière University Hospital, Paris, France.

Malin Kvarnung (M)

Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.

Rita Rodrigues (R)

Neurology Department, Centro Hospitalar Entre Douro e Vouga, Santa Maria da Feira, Portugal.

Elena Pegoraro (E)

Department of Neurosciences DNS, ERN Neuromuscular Centre, University of Padua, Padua, Italy.

Meriem Tazir (M)

Laboratoire de Recherche en Neurosciences, Université d'Alger 1, Service de Neurologie, CHU Mustapha, Place du 1er Mai, 16000, Alger, Algeria.

Frédéric Taithe (F)

CHU de Clermont-Ferrand, 63000, Clermont-Ferrand, France.

Rémi Valter (R)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, DMU Neuroscience 6, Paris, France.
Paris Sciences et Lettres University, EPHE, Paris, France.

Vincent Huin (V)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, DMU Neuroscience 6, Paris, France.

Kristina Lidström (K)

Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.

Guillaume Banneau (G)

APHP, Department of Genetics, Pitié-Salpêtrière University Hospital, Paris, France.

Sara Morais (S)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, DMU Neuroscience 6, Paris, France.
Paris Sciences et Lettres University, EPHE, Paris, France.
UnIGENe, IBMC - Institute for Molecular and Cell Biology, i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.

Livia Parodi (L)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, DMU Neuroscience 6, Paris, France.
Paris Sciences et Lettres University, EPHE, Paris, France.
Department of Biology, University of Padua, Padua, Italy.

Marie Coutelier (M)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, DMU Neuroscience 6, Paris, France.
Paris Sciences et Lettres University, EPHE, Paris, France.

Mélanie Papin (M)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, DMU Neuroscience 6, Paris, France.
Paris Sciences et Lettres University, EPHE, Paris, France.

Per Svenningsson (P)

Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Jean-Philippe Azulay (JP)

Département de Neurologie et Pathologie du Mouvement, Pôle Neurosciences Cliniques, INT-CNRS/AMU Aix-Marseille, Marseille, France.

Isabel Alonso (I)

UnIGENe, IBMC - Institute for Molecular and Cell Biology, i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Genetyca-ICM, Porto, Portugal.

Daniel Nilsson (D)

Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.

Alexis Brice (A)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, DMU Neuroscience 6, Paris, France.

Eric Le Guern (E)

APHP, Department of Genetics, Pitié-Salpêtrière University Hospital, Paris, France.

Rayomand Press (R)

Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Giovanni Vazza (G)

Department of Biology, University of Padua, Padua, Italy.

José Leal Loureiro (JL)

Neurology Department, Centro Hospitalar Entre Douro e Vouga, Santa Maria da Feira, Portugal.

Cyril Goizet (C)

National Reference Center for Rare Diseases 'Neurogenetic', Department of Medical Genetics, Pellegrin Hospital, Bordeaux University Hospital, Bordeaux, France.
Rare Diseases Laboratory: Genetics and Metabolism (MRGM), INSERM U1211, Bordeaux University, Bordeaux, France.

Alexandra Durr (A)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, DMU Neuroscience 6, Paris, France.
APHP, National Reference Center for Rare Diseases 'Neurogenetic', Department of Genetics, Pitié-Salpêtrière University Hospital, Paris, France.

Martin Paucar (M)

Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Giovanni Stevanin (G)

Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, DMU Neuroscience 6, Paris, France. giovanni-b.stevanin@inserm.fr.
Paris Sciences et Lettres University, EPHE, Paris, France. giovanni-b.stevanin@inserm.fr.
APHP, Department of Genetics, Pitié-Salpêtrière University Hospital, Paris, France. giovanni-b.stevanin@inserm.fr.
Institut du Cerveau (ICM), Pitié-Salpêtrière Hospital, CS21414 - 47 bd de l'Hôpital, 75646, Paris, France. giovanni-b.stevanin@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH